Recently, Zhejiang Banger Orthopaedic Medical Group officially announced that it has completed more than 300 million yuan of C-round financing, and the investor is Qiming Venture Capital, a venture capital institution. Prior to this, he obtained nearly 100 million investment in the company in 2014. In 2016, the “Investment Agreement†was officially signed with the Gimpo Medical Service Industry Equity Investment Fund. The total investment of the B-round financing was over RMB 200 million.
Zhejiang Banger Medical Investment Management Co., Ltd. was established in May 2012. Now it has Hangzhou Yuhang Orthopedic Hospital Co., Ltd., Zhangzhou Orthopedic Hospital Co., Ltd., Jiangxi Guangfeng Huashan Hospital, Jinhua Banger Orthopedic Hospital, Jiangshan Bun Orthopedic Hospital, There are 12 orthopedic chain hospitals such as Jiaxing Banger Orthopedic Hospital and Shaoxing Shangyu Banger Orthopaedic Hospital. Except Jiaxing Banger Orthopedic Hospital, which is set up according to the national tertiary hospital, the rest are set according to the national secondary hospital standards. The group's hospitals are specialized hospitals specializing in the diagnosis and treatment of trauma orthopedics, traditional Chinese medicine orthopedics, hand and foot surgery, spinal surgery, joint surgery and rehabilitation. They are also designated medical institutions for medical insurance, agricultural insurance and some commercial insurance, and the group's hospitals. Both of them are associated with Shanghai Huashan Hospital Sports Medicine Center, Fudan University Sports Medicine Center and South Korea Busan Shenteng Hospital.
Hu Xubo, the managing partner of Qiming Ventures, said: China's medical service industry is in an important transition period. The founders and management team of Banger have a deep understanding and long-term commitment to medical technology, operations management and customer service. We are very optimistic about Bol. Throughout the study, we first looked at Zhongbang's focus on the medical technology advantages of orthopedics. At the same time, Banger is currently focusing on grassroots cities, which is in line with the national classification and treatment plan. In addition, Banger has established a group development and operation management system. In the future, we will continue to provide medical technology and medical services in more cities. We look forward to cooperating with Banger and hope to build a leading enterprise in China's orthopaedic medical services with Banger in the future.
Cheng Dong, founder and chairman of the Banger Group, said: Banger’s hard-won today has grown from a single-handed venture in the early days of 2006 to a professional team of more than 3,000 people. Currently, the total number of beds in the group is about 3,500, and the annual operation volume is over 20,000. Taiwan, holding and directly operating 12 orthopedic specialists and general hospitals have relieved the pain of nearly 1 million patients, and have already had a rapid replication basis in terms of expert echelon, medical technology, operation mode, brand building, and hospital management. It has obvious advantages in five major characteristics: orthopedics, spine, joints, hand surgery and rehabilitation. It has become a brand of private specialized hospitals with large scale, strong strength and good reputation in China.
The successful investment of the C-round financing will accelerate the overall layout of the company in the East China market and gradually push it to the national market, which will bring great thrust to the new development of Banger.
GMP Certificated Immune Globulin Injection Supplier in China
Hepatitis B Immunoglobulin,Hep B Immunoglobulin,Hepatitis B Immunoglobulin Vaccine,Hepatitis Immune Globulin
FOSHAN PHARMA CO., LTD. , https://www.fospharma.com